Is the HCV-HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmission?

Vickerman, P; Martin, NK; Roy, A; Beattie, T; Jarlais, DD; Strathdee, S; Wiessing, L; Hickman, M; EMCDDA Collaborative Group, ; , COLLABORATORS; Bao, YP; Caiaffa, W; Ralón, G; Rossi, D; Camoni, L; Suligoi, B; Bergant, N; Brehm Christensen, P; Duarte, Ó, ; Santos, S; Ribeiro, C; Eritsyan, K; Odinokova, V; Vyshinsky, K; Folch, C; Casabona, J; Fotiou, A; Hope, V; Horvath, I; Hutchinson, S; Bogdanova, V; Ilieva, R; Long, J; Matheï, C; Muravsky, A; Prasad, L; Barros, H; Rosinska, M; Roustide, MJ; Scutelniciuc, O; Strathdee, S; Vallejo, F; Uusküla, A; Guarita, B; Noor, A; de la Fuente, L; (2013) Is the HCV-HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmission? Drug and alcohol dependence, 132 (1-2). pp. 172-81. ISSN 0376-8716 DOI:

Full text not available from this repository. (Request a copy)


BACKGROUND: Amongst injecting drug users (IDUs), HIV is transmitted sexually and parenterally, but HCV is transmitted primarily parenterally. We assess and model the antibody prevalence of HCV amongst HIV-infected IDUs (denoted as HCV-HIV co-infection prevalence) and consider whether it proxies the degree of sexual HIV transmission amongst IDUs.<br/> METHODS: HIV, HCV and HCV-HIV co-infection prevalence data amongst IDU was reviewed. An HIV/HCV transmission model was adapted. Multivariate model uncertainty analyses determined whether the model's ability to replicate observed data trends required the inclusion of sexual HIV transmission. The correlation between the model's HCV-HIV co-infection prevalence and estimated proportion of HIV infections due to injecting was evaluated.<br/> RESULTS: The median HCV-HIV co-infection prevalence (prevalence of HCV amongst HIV-infected IDUs) was 90% across 195 estimates from 43 countries. High HCV-HIV co-infection prevalences (>80%) occur in most (75%) settings, but can be lower in settings with low HIV prevalence (<10%) or high HIV/HCV prevalence ratios (HIV prevalence divided by HCV prevalence>0.75). The model without sexual HIV transmission reproduced some data trends but could not reproduce any epidemics with high HIV/HCV prevalence ratios (>0.85) or low HCV-HIV co-infection prevalence (<60%) when HIV prevalence>10%. The model with sexual HIV transmission reproduced data trends more closely. The proportion of HIV infections due to injecting correlated with HCV-HIV co-infection prevalence; suggesting that up to 80/60/<20% of HIV infections could be sexually transmitted in settings with HCV-HIV co-infection prevalence between 50-60/70-80/>90%.<br/> CONCLUSION: Substantial sexual HIV transmission may occur in many IDU populations; HCV-HIV co-infection prevalence could signify its importance.<br/>

Item Type: Article
Faculty and Department: Faculty of Public Health and Policy > Dept of Global Health and Development
Faculty of Epidemiology and Population Health > Dept of Non-Communicable Disease Epidemiology
Research Centre: Social and Mathematical Epidemiology (SaME)
SaME Modelling & Economics
PubMed ID: 23453261
Web of Science ID: 324281400024


Download activity - last 12 months
Downloads since deposit
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item